melatonin has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with melatonin dramatically improved survival rate of rats when compared with the I/R-only group." | 5.31 | Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. ( Chen, HR; Hsiao, G; Lee, YM; Sheu, JR; Wang, JJ; Yen, MH, 2002) |
| "The melatonin-treated animals had longer RR-intervals in the baseline state than the control animals (264 ± 48 ms versus 237 ± 33 ms, p = 0." | 1.62 | Melatonin pretreatment does not modify extrasystolic burden in the rat ischemia-reperfusion model. ( Azarov, JE; Bernikova, OG; Durkina, AV; Gonotkov, MA; Kuzmin, VS; Mikhaleva, NJ; Paderin, NM; Sedova, KA, 2021) |
| "Pretreatment with melatonin dramatically improved survival rate of rats when compared with the I/R-only group." | 1.31 | Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. ( Chen, HR; Hsiao, G; Lee, YM; Sheu, JR; Wang, JJ; Yen, MH, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Durkina, AV | 1 |
| Bernikova, OG | 1 |
| Mikhaleva, NJ | 1 |
| Paderin, NM | 1 |
| Sedova, KA | 1 |
| Gonotkov, MA | 1 |
| Kuzmin, VS | 1 |
| Azarov, JE | 1 |
| Lee, YM | 1 |
| Chen, HR | 1 |
| Hsiao, G | 1 |
| Sheu, JR | 1 |
| Wang, JJ | 1 |
| Yen, MH | 1 |
2 other studies available for melatonin and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Melatonin pretreatment does not modify extrasystolic burden in the rat ischemia-reperfusion model.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Electrocardiography; Heart Rate; Male; Mela | 2021 |
Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hemod | 2002 |